Research
Eli Lilly's drug Retatrutide reduced knee arthritis by as much as 73% in trial participants, and people with moderate to severe sleep apnea recorded roughly 60% fewer breathing interruptions during sleep, according to a study released Tuesday in The Lancet.
Study: Lilly's Retatrutide Cuts Weight, Knee Pain and Sleep Apnea
